Your session is about to expire
← Back to Search
Virtual Reality Training for Airway Injury Management Education (AW&VR Trial)
N/A
Recruiting
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥18 at time of consent
Be older than 18 years old
Must not have
Visual/hearing impairments that affect abilities to listen/watch videos/VR video
Lack of participant consent or capacity to give consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 hours before and up to 24 hours after practice sessions
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether Virtual Reality can be used to educate medical students on airway injury management, and if it is more effective or efficient than training with a mannequin.
Who is the study for?
This trial is for University of Toronto medical students in their 1st, 2nd, or 3rd year who are at least 18 years old and can attend two sessions one week apart. It's not suitable for those without consent capacity, with visual/hearing impairments that limit VR/video use, or a history of significant motion sickness.
What is being tested?
The study tests if VR-based simulation training is as effective as traditional mannequin-based simulation in teaching airway trauma management to medical students. Participants will be randomly assigned to either the VR group or the mannequin group and assessed on their skills after one week.
What are the potential side effects?
Participants may experience side effects from using VR such as motion sickness (cybersickness), which includes symptoms like nausea, dizziness, or headaches.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have visual or hearing impairments that make it hard for me to watch or listen to videos.
Select...
I am able to understand and agree to participate in the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 24 hours before and up to 24 hours after practice sessions
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 hours before and up to 24 hours after practice sessions
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Application of Traumatic Airway Injury Management Knowledge
Change in Traumatic Airway Injury Management Knowledge
Secondary study objectives
Number of Required Practice Sessions
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: VR-based Simulation (Intervention)Experimental Treatment1 Intervention
Students will receive training on traumatic airway management using VR-based simulation.
Group II: Mannequin-based Simulation (Control)Experimental Treatment1 Intervention
Students will receive training on traumatic airway management using mannequin-based simulation.
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
680 Previous Clinical Trials
1,565,826 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of getting very sick from motion, whether it's from physical movement, visual stimulation, or virtual reality. You may also experience cybersickness and have reported it in the past.I can attend two sessions a week apart.I have visual or hearing impairments that make it hard for me to watch or listen to videos.I am 18 years old or older.I am able to understand and agree to participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: VR-based Simulation (Intervention)
- Group 2: Mannequin-based Simulation (Control)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.